We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Factory Location: Ningdong Energy & Chemical Industry Base, Ningxia Province, P.R. China
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Contract Manufacturing: CMO
Sample Provided: yes
Physicochemical Properties:
It is a viscous liquid from colorless to yellowish, and can be dissolved in sodium methoxide in methanol.
Quality Index:
Project
Indicators
Apparent
Clear or Canary Yellow Liquid
Sodium Methoxide
≥ 97.5 %
Content
27.5%～31.0%
Moisture Content
≤0.35%
Function:
It is mainly applied in the pharmaceutical industry, to produce VitamineA1, VitamineB1, the long-acting sulfanilamide, sulfadiazine and trimethoprim, etc. It can also be used in the biodiesel industry and be used as edible catalysts, analytical reagents and cosmetics.
Packing & Storage:
ISO TANK: 20-22 Tons/cans
IBC: 940 kg/IBC
Steel drum, 200 KG/barrel
It should be stored in cool and dry place and kept far away from sources of ignition and of heat. Besides, it should be separated from oxidants and acids during storage and transportation process. Handling with care is needed to keep the package intact.
Four years of qualification
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
![(3aS,6aR)-4-(5-bromopentyl)tetrahydro-1H-thieno[3,4-d]imidazol-2(3H)-one](https://eimg.pharmasources.com/img_Cphi_en/Product/2016_03/Mimg_1603230506861608.gif!145)
![7H-pyrrolo[2,3-d]pyrimidine](https://eimg.pharmasources.com/img_Cphi_en/Product/2016_04/Mimg_1604250502922607.png!145)
![(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-1,3-oxazolidin-2-one](https://eimg.pharmasources.com/img_Cphi_en/Product/2016_05/Mimg_1605260129391947.jpg!145)
